NO2018001I1 - Kombinasjon av glykopyrroniumbromid, formoterol eller et salt derav og beklometasondipropionat - Google Patents
Kombinasjon av glykopyrroniumbromid, formoterol eller et salt derav og beklometasondipropionatInfo
- Publication number
- NO2018001I1 NO2018001I1 NO2018001C NO2018001C NO2018001I1 NO 2018001 I1 NO2018001 I1 NO 2018001I1 NO 2018001 C NO2018001 C NO 2018001C NO 2018001 C NO2018001 C NO 2018001C NO 2018001 I1 NO2018001 I1 NO 2018001I1
- Authority
- NO
- Norway
- Prior art keywords
- formoterol
- salt
- combination
- beclomethasone dipropionate
- glycopyrronium bromide
- Prior art date
Links
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 title 1
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 title 1
- 229950000210 beclometasone dipropionate Drugs 0.000 title 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 title 1
- 229960002848 formoterol Drugs 0.000 title 1
- 229960002462 glycopyrronium bromide Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/04—Methods of, or means for, filling the material into the containers or receptacles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/003—Adding propellants in fluid form to aerosol containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B7/00—Closing containers or receptacles after filling
- B65B7/16—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons
- B65B7/28—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers
- B65B7/2842—Securing closures on containers
- B65B7/285—Securing closures on containers by deformation of the closure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Mechanical Engineering (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09180671 | 2009-12-23 | ||
| EP10799030.1A EP2515855B3 (en) | 2009-12-23 | 2010-12-22 | Combination therapy for COPD |
| PCT/EP2010/070479 WO2011076843A2 (en) | 2009-12-23 | 2010-12-22 | Combination therapy for copd |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO2018001I2 NO2018001I2 (no) | 2018-01-10 |
| NO2018001I1 true NO2018001I1 (no) | 2018-01-10 |
Family
ID=42107420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2018001C NO2018001I1 (no) | 2009-12-23 | 2018-01-10 | Kombinasjon av glykopyrroniumbromid, formoterol eller et salt derav og beklometasondipropionat |
Country Status (40)
| Country | Link |
|---|---|
| US (3) | US20110150782A1 (no) |
| EP (1) | EP2515855B3 (no) |
| JP (2) | JP5914354B2 (no) |
| KR (2) | KR20170040392A (no) |
| CN (2) | CN102665679B (no) |
| AR (2) | AR079726A1 (no) |
| AU (3) | AU2010334859A1 (no) |
| BR (1) | BR112012015337B8 (no) |
| CA (1) | CA2785321C (no) |
| CL (1) | CL2012001705A1 (no) |
| CO (1) | CO6541628A2 (no) |
| CY (2) | CY1115116T1 (no) |
| DK (1) | DK2515855T6 (no) |
| EA (2) | EA027778B1 (no) |
| ES (1) | ES2468840T7 (no) |
| FI (1) | FI2515855T6 (no) |
| GE (1) | GEP20156311B (no) |
| HK (2) | HK1174566A1 (no) |
| HR (1) | HRP20140582T4 (no) |
| HU (1) | HUS1800001I1 (no) |
| IL (1) | IL260932B (no) |
| LT (1) | LTC2515855I2 (no) |
| LU (1) | LUC00060I2 (no) |
| MA (1) | MA33823B1 (no) |
| MX (1) | MX2012006878A (no) |
| MY (1) | MY156949A (no) |
| NL (1) | NL300923I2 (no) |
| NO (1) | NO2018001I1 (no) |
| NZ (1) | NZ600790A (no) |
| PE (2) | PE20160853A1 (no) |
| PL (1) | PL2515855T6 (no) |
| PT (1) | PT2515855E (no) |
| RS (1) | RS53391B2 (no) |
| SG (1) | SG181868A1 (no) |
| SI (1) | SI2515855T1 (no) |
| TN (1) | TN2012000269A1 (no) |
| TW (1) | TWI495468B (no) |
| UA (1) | UA113832C2 (no) |
| WO (1) | WO2011076843A2 (no) |
| ZA (1) | ZA201204615B (no) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2785349C (en) * | 2009-12-23 | 2018-07-03 | Chiesi Farmaceutici S.P.A. | Combination therapy for copd |
| GEP20166479B (en) | 2009-12-23 | 2016-05-25 | Chiesi Farma Spa | Aerosol formulation for copd |
| CN102665679B (zh) * | 2009-12-23 | 2014-11-26 | 奇斯药制品公司 | 用于copd的联合治疗 |
| CA2827045A1 (en) * | 2011-02-17 | 2012-08-23 | Cipla Limited | Compositions of glycopyrrolate and a beta2-agonist |
| CA2850084C (en) | 2011-10-11 | 2020-07-07 | Chiesi Farmaceutici S.P.A. | Crystalline microparticles of a beta-agonist coated with a fatty acid |
| US20150250713A1 (en) * | 2012-10-23 | 2015-09-10 | Cipla Limited | Pharmaceutical Composition |
| WO2015004243A1 (en) | 2013-07-11 | 2015-01-15 | Chiesi Farmaceutici S.P.A. | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation |
| KR101861117B1 (ko) * | 2013-12-30 | 2018-05-28 | 키에시 파르마슈티시 엣스. 피. 에이. | 글리코피로니움 브로마이드 및 포모테롤 조합의 안정한 가압 에어로졸 용액 조성물 |
| MA39154A1 (fr) * | 2013-12-30 | 2017-08-31 | Chiesi Farm Spa | Composition stable pressurisée de solution pour aérosol d'une combinaison de bromure de glycopyrronium et de formotérol |
| US11039620B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
| US11039621B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
| US9622483B2 (en) | 2014-02-19 | 2017-04-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
| US9554992B2 (en) | 2014-06-09 | 2017-01-31 | Chiesi Farmaceutici S.P.A. | Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic |
| GB201416909D0 (en) * | 2014-09-25 | 2014-11-12 | Prosonix Ltd | Method of forming concentrated solution |
| WO2016170518A1 (en) | 2015-04-24 | 2016-10-27 | Glenmark Specialty S.A. | Pharmaceutical compositions comprising arformoterol and glycopyrronium |
| PT3620176T (pt) | 2015-11-16 | 2021-09-28 | Chiesi Farm Spa | Processo para preparar uma formulação de pó seco que compreende um anticolinérgico, um corticosteroide e um beta-adrenérgico |
| GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| MA43782A (fr) | 2016-03-31 | 2021-04-28 | Chiesi Farm Spa | Dispositif d'inhalation d'aérosol |
| US10098837B2 (en) * | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
| MY202069A (en) | 2016-09-19 | 2024-03-31 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| CN115252552A (zh) * | 2016-09-19 | 2022-11-01 | 墨西哥氟石股份公司 | 药物组合物 |
| EP3515425B1 (en) * | 2016-09-19 | 2021-06-09 | Mexichem Fluor S.A. de C.V. | Pharmaceutical composition comprising salmeterol |
| EP3621589B1 (en) | 2017-05-11 | 2021-07-07 | Chiesi Farmaceutici S.p.A. | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic |
| BR112019023378A2 (pt) | 2017-05-11 | 2020-06-16 | Chiesi Farmaceutici S.P.A. | Processo para preparar uma formulação em pó para inalação para uso em um inalador de pó seco |
| JP7475448B2 (ja) | 2019-12-02 | 2024-04-26 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 加圧定量吸入器のためのステンレス鋼缶 |
| MX2023001201A (es) | 2020-07-31 | 2023-05-03 | Chemo Res S L | Terapia combinada para la administracion por inhalacion. |
| EP4225267A1 (en) | 2020-10-09 | 2023-08-16 | Chiesi Farmaceutici S.p.A. | A pharmaceutical formulation for pressurised metered dose inhaler |
| WO2023227782A1 (en) | 2022-05-27 | 2023-11-30 | Chiesi Farmaceutici S.P.A. | A pharmaceutical formulation for pressurised metered dose inhaler |
| WO2023227783A1 (en) | 2022-05-27 | 2023-11-30 | Chiesi Farmaceutici S.P.A. | A pharmaceutical formulation for pressurised metered dose inhaler |
| WO2023227781A1 (en) | 2022-05-27 | 2023-11-30 | Chiesi Farmaceutici S.P.A. | A pharmaceutical formulation for pressurised metered dose inhaler |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2956062A (en) | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
| CZ284203B6 (cs) * | 1992-12-09 | 1998-09-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Tekutý aerosolový přípravek obsahující léčivo a způsob stabilisace tohoto prostředku |
| DE59911149D1 (de) | 1998-07-24 | 2004-12-30 | Jago Res Ag Muttenz | Medizinische aerosolformulierungen |
| ATE234604T1 (de) * | 1998-08-04 | 2003-04-15 | Jago Res Ag | Medizinische aerosolformulierungen |
| US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
| IT1317720B1 (it) | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
| GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| AU2000250701B2 (en) * | 2000-05-22 | 2004-07-01 | Chiesi Farmaceutici S.P.A. | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
| CZ301676B6 (cs) | 2001-03-30 | 2010-05-19 | Jagotec Ag | Farmaceutický suspenzní aerosolový prípravek pro inhalaci a použití soli karboxylové kyseliny |
| US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| EP1321159A1 (en) | 2001-12-21 | 2003-06-25 | CHIESI FARMACEUTICI S.p.A. | Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices |
| CN100398094C (zh) | 2002-03-01 | 2008-07-02 | 奇斯药制品公司 | 福莫特罗超细制剂 |
| CN1726038A (zh) | 2002-12-16 | 2006-01-25 | 贝林格尔英格海姆法玛两合公司 | 含有噻托铵的hfc溶液剂 |
| AR041873A1 (es) * | 2003-10-30 | 2005-06-01 | Pablo Cassara Srl Lab | Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante |
| SI1718336T1 (sl) * | 2004-02-06 | 2008-10-31 | Meda Pharma Gmbh & Co Kg | Nova kombinacija antiholinergika in beta mimetikov za zdravljenje respiratornih bolezni |
| SI1713473T1 (sl) | 2004-02-06 | 2013-06-28 | Meda Pharma Gmbh & Co. Kg | Kombinacija antiholinergikov in glukokortikoidov za dolgotranjno zdravljenje astme in KOPB |
| GB0410399D0 (en) | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| EP1616567A1 (en) | 2004-07-16 | 2006-01-18 | Boehringer Ingelheim Pharma GmbH & Co.KG | Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts |
| GB0505545D0 (en) | 2005-03-17 | 2005-04-27 | Glaxo Group Ltd | Inhalation devices |
| US20090298802A1 (en) | 2005-03-30 | 2009-12-03 | Sequeira Joel A | Pharmaceutical Compositions |
| GB0523653D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| CA2616505A1 (en) | 2005-08-01 | 2007-02-08 | Astrazeneca Ab | Inhaler valve |
| GB0523656D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523654D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523655D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| SI1971369T1 (sl) * | 2005-12-21 | 2009-12-31 | Meda Pharma Gmbh & Co Kg | Kombinacija R,R-glikopirolata,roliprama in budezonida za zdravljenje vnetnih bolezni |
| GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| EP1894568A1 (en) * | 2006-08-31 | 2008-03-05 | Novartis AG | Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| US8618160B2 (en) | 2007-10-18 | 2013-12-31 | Rose U | Topical glycopyrrolate formulations |
| WO2010144628A2 (en) * | 2009-06-09 | 2010-12-16 | Elevation Pharmaceuticals, Inc. | Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration |
| GEP20166479B (en) * | 2009-12-23 | 2016-05-25 | Chiesi Farma Spa | Aerosol formulation for copd |
| RU2567040C2 (ru) * | 2009-12-23 | 2015-10-27 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Аэрозольная препаративная форма для лечения по поводу хронического обструктивного легочного заболевания |
| CN102665679B (zh) * | 2009-12-23 | 2014-11-26 | 奇斯药制品公司 | 用于copd的联合治疗 |
| CA2785349C (en) | 2009-12-23 | 2018-07-03 | Chiesi Farmaceutici S.P.A. | Combination therapy for copd |
| WO2015004243A1 (en) * | 2013-07-11 | 2015-01-15 | Chiesi Farmaceutici S.P.A. | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation |
| KR101861117B1 (ko) | 2013-12-30 | 2018-05-28 | 키에시 파르마슈티시 엣스. 피. 에이. | 글리코피로니움 브로마이드 및 포모테롤 조합의 안정한 가압 에어로졸 용액 조성물 |
| MA39154A1 (fr) * | 2013-12-30 | 2017-08-31 | Chiesi Farm Spa | Composition stable pressurisée de solution pour aérosol d'une combinaison de bromure de glycopyrronium et de formotérol |
| US9554992B2 (en) * | 2014-06-09 | 2017-01-31 | Chiesi Farmaceutici S.P.A. | Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic |
| US10098837B2 (en) * | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
-
2010
- 2010-12-22 CN CN201080058048.8A patent/CN102665679B/zh active Active
- 2010-12-22 KR KR1020177009412A patent/KR20170040392A/ko active Search and Examination
- 2010-12-22 JP JP2012545323A patent/JP5914354B2/ja active Active
- 2010-12-22 SG SG2012046157A patent/SG181868A1/en unknown
- 2010-12-22 TW TW099145166A patent/TWI495468B/zh active
- 2010-12-22 AU AU2010334859A patent/AU2010334859A1/en not_active Abandoned
- 2010-12-22 PL PL10799030.1T patent/PL2515855T6/pl unknown
- 2010-12-22 GE GEAP201012756A patent/GEP20156311B/en unknown
- 2010-12-22 KR KR1020127015996A patent/KR101757951B1/ko active IP Right Grant
- 2010-12-22 PE PE2016000787A patent/PE20160853A1/es unknown
- 2010-12-22 AR ARP100104922A patent/AR079726A1/es not_active Application Discontinuation
- 2010-12-22 SI SI201030654T patent/SI2515855T1/sl unknown
- 2010-12-22 CA CA2785321A patent/CA2785321C/en active Active
- 2010-12-22 CN CN201410289445.6A patent/CN104055765B/zh active Active
- 2010-12-22 BR BR112012015337A patent/BR112012015337B8/pt active IP Right Grant
- 2010-12-22 RS RS20140338A patent/RS53391B2/sr unknown
- 2010-12-22 ES ES10799030T patent/ES2468840T7/es active Active
- 2010-12-22 MY MYPI2012002844A patent/MY156949A/en unknown
- 2010-12-22 PE PE2012000865A patent/PE20121396A1/es not_active Application Discontinuation
- 2010-12-22 EP EP10799030.1A patent/EP2515855B3/en active Active
- 2010-12-22 DK DK10799030.1T patent/DK2515855T6/da active
- 2010-12-22 EA EA201590179A patent/EA027778B1/ru active Protection Beyond IP Right Term
- 2010-12-22 PT PT107990301T patent/PT2515855E/pt unknown
- 2010-12-22 NZ NZ600790A patent/NZ600790A/en unknown
- 2010-12-22 MX MX2012006878A patent/MX2012006878A/es active IP Right Grant
- 2010-12-22 UA UAA201207626A patent/UA113832C2/uk unknown
- 2010-12-22 WO PCT/EP2010/070479 patent/WO2011076843A2/en active Application Filing
- 2010-12-22 EA EA201290375A patent/EA021917B1/ru active Protection Beyond IP Right Term
- 2010-12-23 US US12/977,159 patent/US20110150782A1/en not_active Abandoned
-
2012
- 2012-05-29 TN TNP2012000269A patent/TN2012000269A1/en unknown
- 2012-06-01 CO CO12092198A patent/CO6541628A2/es unknown
- 2012-06-14 MA MA34966A patent/MA33823B1/fr unknown
- 2012-06-21 CL CL2012001705A patent/CL2012001705A1/es unknown
- 2012-06-21 ZA ZA2012/04615A patent/ZA201204615B/en unknown
-
2013
- 2013-02-15 HK HK13101936.0A patent/HK1174566A1/xx unknown
-
2014
- 2014-05-29 CY CY20141100382T patent/CY1115116T1/el unknown
- 2014-06-23 HR HRP20140582TT patent/HRP20140582T4/hr unknown
- 2014-10-23 HK HK14110591A patent/HK1197036A1/xx unknown
-
2015
- 2015-07-29 US US14/812,190 patent/US10159645B2/en active Active
-
2016
- 2016-04-04 JP JP2016075136A patent/JP6283388B2/ja active Active
- 2016-09-27 AU AU2016234895A patent/AU2016234895B2/en active Active
-
2017
- 2017-12-22 CY CY2017047C patent/CY2017047I1/el unknown
- 2017-12-29 FI FIEP10799030.1T patent/FI2515855T6/fi active
-
2018
- 2018-01-05 HU HUS1800001C patent/HUS1800001I1/hu unknown
- 2018-01-10 LU LU00060C patent/LUC00060I2/fr unknown
- 2018-01-10 NO NO2018001C patent/NO2018001I1/no unknown
- 2018-01-11 LT LTPA2018001C patent/LTC2515855I2/lt unknown
- 2018-01-12 NL NL300923C patent/NL300923I2/en unknown
- 2018-04-30 AU AU2018202998A patent/AU2018202998A1/en not_active Abandoned
- 2018-08-01 IL IL260932A patent/IL260932B/en active IP Right Grant
- 2018-10-16 US US16/161,427 patent/US11389401B2/en active Active
-
2019
- 2019-08-02 AR ARP190102199A patent/AR115897A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2018001I1 (no) | Kombinasjon av glykopyrroniumbromid, formoterol eller et salt derav og beklometasondipropionat | |
| NO2019026I1 (no) | Kombinasjon av glykopyrrolat (inkludert eventuelle farmasøytisk akseptable salter, estere eller enantiomerer derav) og formoterol (innbefattende hvilke som helst farmasøytisk akseptable salter, estere eller enantiomerer derav) | |
| NO2018018I1 (no) | Farmasøytisk kombinasjonsprodukt omfattende et farmasøytisk akseptabelt salt av umeklidinium (for eksempel umeklidiniumbromid), vilanterol eller et farmasøytisk akseptabelt salt derav (for eksempel vilanteroltrifenatat) og flutikasonfuroate | |
| BR112013013308A2 (pt) | inalador e unidade articulada | |
| DK2220320T3 (da) | Forseglet enhed og mellemstykke | |
| DK2544719T3 (da) | Cd37-bindingsmolekyler og immunkonjugater deraf | |
| DK2635142T4 (da) | Røgfrie tobaksprodukter og fremgangsmåder | |
| BR112013009069A2 (pt) | instrumentação unida ao paciente e métodos | |
| DK2419732T3 (da) | Prionfrie nanopartikelsammensætninger og fremgangsmåder | |
| DK2572102T4 (da) | Rotorvingeelement og fremgangsmåde til forbedring af effektiviteten af en vindmøllerotorvinge | |
| DK3127540T3 (da) | Visse amino-pyrimidiner, sammensætninger deraf, og fremgangsmåder til deres anvendelse | |
| BR112013013584A2 (pt) | endoscópio, e, método | |
| DK2584921T3 (da) | Sondeernæringspakninger og fremgangsmåder til anvendelse deraf | |
| DK2313404T3 (da) | Quinuclidin-carbonat-derivater og medicinsk sammensætning deraf | |
| FI20096058A0 (fi) | Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä | |
| DK2592938T3 (da) | Mejeriprodukt og fremgangsmåde | |
| DK2406372T3 (da) | Prægastrisk esterase og derivater deraf | |
| DK3144325T3 (da) | Heparin med høj renhed og fremstillingsfremgangsmåde dertil | |
| IT1403200B1 (it) | Metodo ed unità di piegatura di assorbenti igienici. | |
| DK2588097T3 (da) | Farmaceutiske sammensætninger omfattende paracetamol og fremgangsmåde til fremstilling af samme | |
| BR112012007484A2 (pt) | formulações aerossóis farmacêuticas de formoterol e dipropionato de beclometasona | |
| FI20106377A (fi) | Paineventtiili ja venttiilikehysrakenne | |
| DK2536591T3 (da) | Advarselslysanordning; komponenter; og fremgangsmåder | |
| NO345068B1 (no) | Nedihulls rørekspander og fremgangsmåte | |
| BR112013008812A2 (pt) | composição e método |